A major sex difference in Alzheimer’s disease (AD) is that men with the disease die earlier
than do women. In aging and preclinical AD, men also show more cognitive deficits. Here, we …

We have shown that 17β-estradiol exerts profound protective effects against stroke-like
ischemic injury in female rats. These effects are evident using physiological levels of estradiol …

Aging is the primary risk factor for cognitive decline, an emerging health threat to aging
societies worldwide. Whether anti-aging factors such as klotho can counteract cognitive decline …

An accumulating body of evidence clearly establishes that estradiol is a potent neuroprotective
and neurotrophic factor in the adult: it influences memory and cognition, decreases the …

Estradiol protects against brain injury, neurodegeneration, and cognitive decline. Our previous
work demonstrates that physiological levels of estradiol protect against stroke injury and …

Clinical studies demonstrate that estrogen replacement therapy in postmenopausal women
may enhance cognitive function and reduce neurodegeneration associated with Alzheimer's …

We have shown that physiological levels of estradiol exert profound protective effects on the
cerebral cortex in ischemia induced by permanent middle cerebral artery occlusion. The …

Amyloid-β oligomers may cause cognitive deficits in Alzheimer’s disease by impairing
neuronal NMDA-type glutamate receptors, whose function is regulated by the receptor tyrosine …

Astrocytes express a variety of G protein–coupled receptors and might influence cognitive
functions, such as learning and memory. However, the roles of astrocytic G s -coupled …

More than 5 million Americans are living with Alzheimer's disease (AD) today, and nearly
two-thirds of Americans with AD are women. This sex difference may be due to the higher …